Revolution Medicines, Inc. Warrant share price logo

Revolution Medicines, Inc. Warrant

NASDAQ: RVMDW

$5.84

-0.01

(-0.17%)

as on

Revolution Medicines, Inc. Warrant Stock Performance

as on May 23, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $5.75
    $6.27
    downward going graph

    1.54%

    Downside

    7.36%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Revolution Medicines, Inc. Warrant share price movements today

Previous Close
$5.85
Open
$6.07
Volume
544.0K
Day's Low - High
$5.75 - $6.27

Revolution Medicines, Inc. Warrant Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Revolution Medicines, Inc. Warrant Stock Fundamentals & Key Indicators

Check Revolution Medicines, Inc. Warrant market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-76.67%

Revolution Medicines, Inc. Warrant stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Revolution Medicines, Inc. Warrant with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Revolution Medicines, Inc. Warrant image
Revolution Medicines, Inc. Warrant
NA$-NANA0.00%

Revolution Medicines, Inc. Warrant Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
-
-
261
-
-
-
-
-
Gross Profit
0
-118
-12
-151
-188
-205
-3
-
-4
-4
Operating Income
-179
-140
-156
-175
-216
-240
-264
-315
-361
-445
EBITDA
-129
-138
-153
-153
-212
-237
-260
-289
-348
-440
Interest Expense
9
-
-
-
-
-
0
11
11
12
Depreciation
2
2
2
2
3
3
3
4
4
4
Income Before Tax
-161
-116
-133
-156
-195
-213
-247
-305
-364
-453
Income Tax Expense
0
-2
-
-156
0
-
-
-
-
-
Net Income
-161
-116
-133
-156
-194
-213
-247
-305
-364
-453
Net Profit Margin
-21770.49%
0.00%
0.00%
0.00%
-74.38%
0.00%
0.00%
0.00%
0.00%
0.00%

Revolution Medicines, Inc. Warrant Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
20
50
42
29
35
11
-
-
Gross Profit
20
50
42
29
35
11
-592
-16
Operating Income
-40
-54
-110
-188
-258
-487
-689
-1,182
EBITDA
-39
-48
-101
-179
-248
-477
-677
-1,090
Interest Expense
0
0
0
0
9
0
-
24
Depreciation
-
4
6
7
9
9
11
16
Income Before Tax
-41
-52
-108
-187
-249
-439
-600
-1,131
Income Tax Expense
-1
-4
0
-7
0
-3
0
-
Net Income
-41
-47
-108
-187
-248
-436
-600
-1,131
Net Profit Margin
-207.24%
-95.25%
-251.63%
-636.58%
-702.95%
-3768.28%
0.00%
0.00%

Revolution Medicines, Inc. Warrant Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-116
-133
-156
-194
-213
-247
-305
-364
-453
Operating Cash Flow
-160
-128
-130
-138
-194
-221
-207
-274
-354
Investing Cash Flow
-247
107
-21
-392
-15
34
24
74
172
Financing Cash Flow
0
7
77
873
0
256
-1
365
238
Change in Cash
-407
-12
-74
341
-209
69
-184
166
57

Revolution Medicines, Inc. Warrant Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-41
-47
-108
-187
-248
-436
-600
-1,131
Operating Cash Flow
1
-49
-100
-147
-224
-350
-557
-897
Investing Cash Flow
-1
-101
-234
-142
-24
-342
-554
118
Financing Cash Flow
60
98
422
294
301
1,229
959
621
Change in Cash
60
-52
88
4
52
534
-153
-158

About Revolution Medicines, Inc. Warrant

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
OrganisationRevolution Medicines, Inc. Warrant
Headquarters700 Saginaw Drive, Redwood City, CA, United States, 94063
IndustryHealth Care
CEODr. Mark A. Goldsmith M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Revolution Medicines, Inc. Warrant

Name

Title

Mr. Jeffrey Cislini J.D.

Senior VP, General Counsel & Corporate Secretary

Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.

President of Research & Development

Dr. Michael A. Fischbach Ph.D.

Academic Co-Founder & Member of Scientific Advisory Board

Dr. Kevan M. Shokat Ph.D.

Academic Co-Founder & Member of Scientific Advisory Board

Mr. Walter Reiher Ph.D.

Chief Information Officer

Ms. Jan Smith Ph.D.

Chief Scientific Officer

Dr. Mark A. Goldsmith M.D., Ph.D.

CEO, President & Chairman

Mr. Jack Anders

Chief Financial Officer

Ms. Margaret A. Horn J.D.

Chief Operating Officer

Dr. Martin D. Burke M.D., Ph.D.

Co-Founder & Chairman of Scientific Advisory Board

FAQs

What is Revolution Medicines, Inc. Warrant share price today?

Revolution Medicines, Inc. Warrant share price today is $5.84 as on at the close of the market. Revolution Medicines, Inc. Warrant share today touched a day high of $6.27 and a low of $5.75.

What is the 52 week high and 52 week low for Revolution Medicines, Inc. Warrant share?

Revolution Medicines, Inc. Warrant share touched a 52 week high of $ on and a 52 week low of $ on . Revolution Medicines, Inc. Warrant stock price today i.e. is closed at $5.84,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in Revolution Medicines, Inc. Warrant Stock (RVMDW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Revolution Medicines, Inc. Warrant on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Revolution Medicines, Inc. Warrant Shares that will get you 0.2568 shares as per Revolution Medicines, Inc. Warrant share price of $5.84 per share as on May 23, 2026 at 8:46 am IST.

What is the minimum amount required to buy Revolution Medicines, Inc. Warrant Stock (RVMDW) from India?

Indian investors can start investing in Revolution Medicines, Inc. Warrant (RVMDW) shares with as little as ₹95.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.80 in Revolution Medicines, Inc. Warrant stock (as per the Rupee-Dollar exchange rate as on ). Based on Revolution Medicines, Inc. Warrant share’s latest price of $5.84 as on May 23, 2026 at 8:46 am IST, you will get 1.7123 shares of Revolution Medicines, Inc. Warrant. Learn more about fractional shares .